MCLife Fighting Against Cystic Fibrosis in Tulsa With the #CFShoeSelfie Movement
By: MC Companies
SCOTTSDALE, Ariz. - April 13, 2015 - PRLog -- Every day we are bombarded with images: emails, social media, television, and advertisements throw things at us at rapid speed. How many images of these stick with you and how many of them are important? We want you to look through the clutter and mess to see the importance of #CFShoeSelfie images. MCLife, the residential apartment brand of MC Companies, has created the #CFShoeSelfie movement to raise awareness about cystic fibrosis.
What is a #CFShoeSelfie?
Along with our social media campaign, we are taking part in Great Strides walks throughout the country. On Saturday, May 16, 2015, we will be participating in Great Strides Tulsa. These Great Strides walks are the #1 fundraising events for the Cystic Fibrosis Foundation. The Cystic Fibrosis Foundation is helping the 30,000 people living with Cystic Fibrosis in the United States through medical research and the advancement of specialized medical care. They need your help to keep their journey alive.
You can make a positive impact and make a difference for those suffering from cystic fibrosis. Join us on Saturday, May 16, 2015, at Great Strides Tulsa. You can join our team, make a donation and add your voice to the conversation. There are fundraising toolkits and resources that can help you spread the word and become an advocate. We hope you will walk with us and pave the way for a brighter tomorrow.
# # # #
About MC Companies: MC Companies http://www.mccompanies.com is a real estate investment, development, construction, and management company specializing in the multifamily properties and commercial markets. MC Companies has completed over $500 million in multi-family and commercial value-added transactions since 1985.
About the Cystic Fibrosis Foundation: The mission of the Cystic Fibrosis Foundation is “to cure cystic fibrosis and to provide all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment, and ensuring access to high-quality, specialized care.”
Page Updated Last on: Apr 13, 2015